secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2026-06-10T20:02:32+00:00
Accession:  0001398733-26-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive Therapeutics shareholders elect three Class II directors at 2026 annual meeting
--------------------------------------------------------------------------------

- Gregory B. Brown, M.D. elected with 41,373,033 votes for; 1,222,711 against.
- John S. Cochran elected with 36,914,899 votes for; 5,680,845 against.
- Abigail L. Jenkins elected with 39,094,166 votes for; 3,501,578 against.
- Advisory say-on-pay proposal passed: 37,798,609 for, 3,192,381 against.
- KPMG LLP ratified as independent auditor for FY 2026 with 78,804,323 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000033/0001398733-26-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000139873326000033/aqst-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001398733-26-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer